Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07226648 · ClinicalTrials.gov registry record · NA

Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia

A NA study of Fibromyalgia, sponsored by SPIRE Therapeutics.

Recruiting
Registry status
NA
Development phase
180
Enrollment target
2
Study locations

NCT07226648 is a NA study of Fibromyalgia that is actively recruiting participants, run by SPIRE Therapeutics. The registered enrollment target is 180 participants, roughly in line with the 177-participant average among 76 other Fibromyalgia trials with a reported enrollment target. The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07226648, a NA study of Fibromyalgia, is actively recruiting participants, sponsored by SPIRE Therapeutics.

RECRUITING
Registry status
NA
Development phase
180 participants
Enrollment target
2
Study locations

Study Summary

The goal of this clinical trial is to evaluate a new noninvasive brain stimulation intervention for fibromyalgia and to determine its effectiveness in reducing pain. Participants will receive four treatments over the course of one month and will complete surveys at multiple time points throughout the 16-week study.

Conditions Studied

Interventions

  • DEVICE Focused Ultrasound

Study Locations (2)

Minnesota

  • University of Minnesota Medical Center Fairview - Minneapolis

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2025-12-11
Est. Completion 2026-12
Phase NA

Sponsor

SPIRE Therapeutics

1 total trials

What the Registry Record Tells You About NCT07226648

The ClinicalTrials.gov registry entry for NCT07226648 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 177-participant average among 76 other Fibromyalgia trials with a reported enrollment target. The listed sponsor is SPIRE Therapeutics, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Fibromyalgia appearing as the primary indexed condition, and to 1 intervention - of which Focused Ultrasound is the first listed.

NCT07226648 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Minnesota, Utah.

Frequently Asked Questions

What is clinical trial NCT07226648 about?

NCT07226648 is a clinical study titled "Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia". The goal of this clinical trial is to evaluate a new noninvasive brain stimulation intervention for fibromyalgia and to determine its effectiveness in reducing pain. Participants will receive four treatments over the course of one month and will complete surveys at multiple time points throughout th...

What is the current status of trial NCT07226648?

This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2025-12-11. Estimated completion is 2026-12.

What conditions does trial NCT07226648 study?

This clinical trial studies the following conditions: Fibromyalgia.

What interventions are being tested in trial NCT07226648?

The interventions under investigation include: Focused Ultrasound (DEVICE).

Who is sponsoring clinical trial NCT07226648?

This trial is sponsored by SPIRE Therapeutics, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07226648 being conducted?

This trial has 2 study locations across Minnesota, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fibromyalgia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.